Roberts Eric W's Form 4/A amendment
AmendedCalciMedica, Inc.CALC · filed Nov 6, 2024
- Accession no.
- 0001415889-24-026280
- Filed
- Nov 6, 2024
- Trade date
- May 17, 2023
- Filing delay
- 539 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- May 18, 2023
This filing lists 1 non-derivative transaction. It carries over 2 transactions from the original filing that it did not restate. Open-market purchases total $22.4K. It was filed 539 days after the trade.
This amendment restates part of 0001209191-23-030779 (filed May 18, 2023). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Roberts Eric WCIK 0001576244 | Director, Officer (CHIEF BUSINESS OFFICER), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 17, 2023 | Common Stock | PPurchaseAcquired | +3,000 | $2.68 | +$8,040 | 3,000 | Indirect |
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0001209191-23-030779 (filed May 18, 2023).
Non-derivative securities (Table I)
Footnotes on the original
The footnotes that the prices of these transactions refer to on the original filing.
- F1
The weighted average purchase price for the transaction reported was $2.72, and the range of prices were between $2.60 and $2.76. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
Referenced by the price of 1 transaction in Table I.
- F2
The weighted average purchase price for the transaction reported was $2.71, and the range of prices were between $2.65 and $2.75. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
Referenced by the price of 1 transaction in Table I.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
On May 18, 2023, the Reporting Person filed a Form 4 which inadvertently omitted the purchase of 3,000 shares of the Issuer's common stock by Oppenheimer & Co Inc. Custodian FBO Eric W Roberts Roth IRA (the "Oppenheimer IRA"). In fact, as reported in this amendment, the Reporting Person indirectly owned 3,000 shares of common stock held by the Oppenheimer IRA following the purchase.